113 related articles for article (PubMed ID: 6145778)
1. Elevation of serum corticosterone in rats by bremazocine, a kappa-opioid agonist.
Fuller RW; Leander JD
J Pharm Pharmacol; 1984 May; 36(5):345-6. PubMed ID: 6145778
[TBL] [Abstract][Full Text] [Related]
2. Bremazocine-induced backwards walking behavior in rats is mediated via opioid kappa receptors.
Shearman GT; Stenfors C
Pharmacol Biochem Behav; 1986 Apr; 24(4):861-3. PubMed ID: 3012599
[TBL] [Abstract][Full Text] [Related]
3. Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action.
Salas SP; Roblero J; Ureta H; Huidobro-Toro JP
J Pharmacol Exp Ther; 1989 Sep; 250(3):992-9. PubMed ID: 2550625
[TBL] [Abstract][Full Text] [Related]
4. The influence of the kappa-agonist bremazocine on ingestive behaviour in mice and rats.
Hartig U; Opitz K
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):4-12. PubMed ID: 6307194
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of the respiratory depressant and analgesic effects of bremazocine, a kappa-agonist.
Pazos A; Tristán C; Flórez J
Life Sci; 1983; 33 Suppl 1():579-81. PubMed ID: 6319913
[TBL] [Abstract][Full Text] [Related]
6. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
[TBL] [Abstract][Full Text] [Related]
7. Opiate control of spontaneous locomotor activity in a urodele amphibian.
Deviche P; Lowry CA; Moore FL
Pharmacol Biochem Behav; 1989 Dec; 34(4):753-7. PubMed ID: 2560213
[TBL] [Abstract][Full Text] [Related]
8. Bremazocine: a potent, long-acting opiate kappa-agonist.
Römer D; Büscher H; Hill RC; Maurer R; Petcher TJ; Welle HB; Bakel HC; Akkerman AM
Life Sci; 1980 Sep; 27(11):971-8. PubMed ID: 6253759
[No Abstract] [Full Text] [Related]
9. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. II. GH and PRL release-inhibiting effects of the opioid kappa receptor agonists bremazocine and U-50,488.
Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
Neuroendocrinology; 1986; 42(1):82-7. PubMed ID: 3001566
[TBL] [Abstract][Full Text] [Related]
10. Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels.
Hayes AG; Stewart BR
Eur J Pharmacol; 1985 Oct; 116(1-2):75-9. PubMed ID: 2996912
[TBL] [Abstract][Full Text] [Related]
11. Biphasic effect of a kappa-opioid receptor agonist on plasma oxytocin levels in rats.
Grell S; Fjalland B; Christensen JD
Eur J Pharmacol; 1989 Jul; 166(1):41-8. PubMed ID: 2553430
[TBL] [Abstract][Full Text] [Related]
12. Further study of kappa opioids on increased urination.
Leander JD
J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
[TBL] [Abstract][Full Text] [Related]
13. Bremazocine causes sympatho-inhibition and hypotension in rabbits by activating peripheral kappa-receptors.
Ensinger H; Hedler L; Szabo B; Starke K
J Cardiovasc Pharmacol; 1986; 8(3):470-5. PubMed ID: 2425160
[TBL] [Abstract][Full Text] [Related]
14. Kappa-opiates and urination: pharmacological evidence for an endogenous role of the kappa-opiate receptor in fluid and electrolyte balance.
Huidobro-Toro JP; Parada S
Eur J Pharmacol; 1984 Dec; 107(1):1-10. PubMed ID: 6098480
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of a new opioid agonist on reproductive endocrine activity in rats of both sexes.
Markó M; Römer D
Life Sci; 1983 Jul; 33(3):233-40. PubMed ID: 6865656
[TBL] [Abstract][Full Text] [Related]
16. Kappa-receptor antagonist reverse 'non-opioid' stress-induced analgesia.
Panerai AE; Martini A; Sacerdote P; Mantegazza P
Brain Res; 1984 Jun; 304(1):153-6. PubMed ID: 6331578
[TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
[TBL] [Abstract][Full Text] [Related]
18. Bremazocine is an agonist at kappa-opioid receptors and an antagonist at mu-opioid receptors in the guinea-pig myenteric plexus.
Corbett AD; Kosterlitz HW
Br J Pharmacol; 1986 Sep; 89(1):245-9. PubMed ID: 3026544
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of nociceptive flexion reflex discharge by the kappa agonist bremazocine.
Banna NR; Al-Amin HA; Jabbur SJ
Neuropharmacology; 1987; 26(2-3):271-4. PubMed ID: 3035416
[TBL] [Abstract][Full Text] [Related]
20. Effects of mu- and kappa-opioid receptor agonists on urinary output in mice.
Rathbun RC; Kattau RW; Leander JD
Pharmacol Biochem Behav; 1983 Nov; 19(5):863-6. PubMed ID: 6316374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
